EE200300008A - COMT-i inhibeeriva aktiivsusega kumariini derivaadid - Google Patents

COMT-i inhibeeriva aktiivsusega kumariini derivaadid

Info

Publication number
EE200300008A
EE200300008A EEP200300008A EEP200300008A EE200300008A EE 200300008 A EE200300008 A EE 200300008A EE P200300008 A EEP200300008 A EE P200300008A EE P200300008 A EEP200300008 A EE P200300008A EE 200300008 A EE200300008 A EE 200300008A
Authority
EE
Estonia
Prior art keywords
sub
inhibitory activity
coumarin derivatives
comt inhibitory
comt
Prior art date
Application number
EEP200300008A
Other languages
English (en)
Estonian (et)
Inventor
Pystynen Jarmo
Ovaska Martti
Vidgren Jukka
Lotta Timo
Yliperttula-Ikonen Marjo
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of EE200300008A publication Critical patent/EE200300008A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200300008A 2000-07-03 2001-06-28 COMT-i inhibeeriva aktiivsusega kumariini derivaadid EE200300008A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20001593A FI20001593A (fi) 2000-07-03 2000-07-03 Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
PCT/FI2001/000613 WO2002002548A1 (en) 2000-07-03 2001-06-28 Coumarin derivatives with comt inhibiting activity

Publications (1)

Publication Number Publication Date
EE200300008A true EE200300008A (et) 2004-08-16

Family

ID=8558717

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300008A EE200300008A (et) 2000-07-03 2001-06-28 COMT-i inhibeeriva aktiivsusega kumariini derivaadid

Country Status (27)

Country Link
US (1) US6951870B2 (xx)
EP (1) EP1301503B1 (xx)
JP (1) JP4851051B2 (xx)
KR (1) KR20030040225A (xx)
CN (1) CN1199963C (xx)
AT (1) ATE260268T1 (xx)
AU (2) AU7259701A (xx)
BG (1) BG107513A (xx)
BR (1) BR0111969A (xx)
CA (1) CA2414787C (xx)
DE (1) DE60102161T2 (xx)
DK (1) DK1301503T3 (xx)
EE (1) EE200300008A (xx)
ES (1) ES2215919T3 (xx)
FI (1) FI20001593A (xx)
HU (1) HUP0301706A3 (xx)
IL (2) IL153352A0 (xx)
MX (1) MXPA02012657A (xx)
NO (1) NO328699B1 (xx)
NZ (1) NZ523121A (xx)
PL (1) PL359068A1 (xx)
PT (1) PT1301503E (xx)
RU (1) RU2282627C2 (xx)
SK (1) SK18452002A3 (xx)
TR (1) TR200400802T4 (xx)
WO (1) WO2002002548A1 (xx)
ZA (1) ZA200210161B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
AU2003265737B2 (en) * 2002-10-02 2008-10-16 Novogen Research Pty Ltd Combination chemotherapy compositions and methods
CN1506359A (zh) * 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
CN101056868B (zh) 2004-09-21 2012-05-02 马休爱德华兹股份有限公司 取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
MY148644A (en) * 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
US8686002B2 (en) 2005-08-21 2014-04-01 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
WO2007124617A1 (fr) * 2006-04-28 2007-11-08 Institute Of Mataria Medica, Chinese Academy Of Medical Sciences Dérivés de coumarine, leurs procédés de préparation, compositions pharmaceutiques et utilisations
ES2343347B2 (es) * 2009-01-27 2011-12-07 Universidade De Santiago De Compostela Uso de derivados de 3-fenilcumarinas 6-sustituidas y preparacion de nuevos derivados.
CA2816319C (en) 2010-11-01 2020-06-30 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚ｏ－甲基轉移酶活性抑制化合物
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra
EP3390351A1 (en) * 2015-12-18 2018-10-24 Koester, Hubert Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease
CN107868069A (zh) * 2017-10-31 2018-04-03 山东新华制药股份有限公司 7‑羟基‑8‑甲基‑6‑硝基‑2‑氧‑2h‑苯并吡喃‑3‑羧酸的制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3973608A (en) 1973-08-01 1976-08-10 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Microbial production of certain isoflavones
JPS5035393A (xx) * 1973-08-01 1975-04-04
US5236952A (en) * 1986-03-11 1993-08-17 Hoffmann-La Roche Inc. Catechol derivatives
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
GB8816519D0 (en) 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
HUT63843A (en) 1992-02-13 1993-10-28 Biosignal Kutato Fejlesztoe Kf Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds
JP3166094B2 (ja) * 1993-09-08 2001-05-14 森永乳業株式会社 クマリン誘導体及びそれらの用途
JPH0892157A (ja) 1994-05-02 1996-04-09 F Hoffmann La Roche Ag プルプロガリン誘導体
GB9626472D0 (en) 1996-12-20 1997-02-05 Aperia Anita C New use of comt inhibitors

Also Published As

Publication number Publication date
HUP0301706A2 (hu) 2003-09-29
TR200400802T4 (tr) 2004-07-21
DE60102161T2 (de) 2004-09-16
RU2282627C2 (ru) 2006-08-27
NO328699B1 (no) 2010-04-26
ES2215919T3 (es) 2004-10-16
JP2004502684A (ja) 2004-01-29
FI20001593A0 (fi) 2000-07-03
EP1301503A1 (en) 2003-04-16
HUP0301706A3 (en) 2005-12-28
ZA200210161B (en) 2004-03-15
CA2414787C (en) 2010-12-14
AU2001272597B2 (en) 2005-07-21
WO2002002548A1 (en) 2002-01-10
US20030186975A1 (en) 2003-10-02
EP1301503B1 (en) 2004-02-25
CN1440399A (zh) 2003-09-03
BG107513A (bg) 2003-06-30
ATE260268T1 (de) 2004-03-15
SK18452002A3 (sk) 2004-04-06
CN1199963C (zh) 2005-05-04
NO20026095D0 (no) 2002-12-18
NO20026095L (no) 2003-03-03
DK1301503T3 (da) 2004-06-28
AU7259701A (en) 2002-01-14
DE60102161D1 (de) 2004-04-01
FI20001593A (fi) 2002-01-04
IL153352A (en) 2009-05-04
NZ523121A (en) 2004-08-27
BR0111969A (pt) 2003-07-01
US20040110750A9 (en) 2004-06-10
IL153352A0 (en) 2003-07-06
PT1301503E (pt) 2004-06-30
CA2414787A1 (en) 2002-01-10
US6951870B2 (en) 2005-10-04
KR20030040225A (ko) 2003-05-22
AU2001272597B9 (en) 2005-08-11
PL359068A1 (en) 2004-08-23
MXPA02012657A (es) 2003-05-14
JP4851051B2 (ja) 2012-01-11

Similar Documents

Publication Publication Date Title
EE200300008A (et) COMT-i inhibeeriva aktiivsusega kumariini derivaadid
DK0931788T3 (da) Metalloproteasehæmmere
ATE270817T1 (de) Fungizide
SE0004245D0 (sv) Novel compounds and their use
ATE511352T1 (de) Antimikrobielle zusammensetzungen
ATE258930T1 (de) Dihydrobenzifurane
AP2002002554A0 (en) Ox (ADI) azolyl-hydroxamic acids useful as procollagen C- proteinase inhibitors.
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
WO2004099130A3 (en) 1,2-diarylimidazoles useful as inhibitors of cox
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
ES2159489A1 (es) Nuevos derivados de imidazol con actividad antiinflamatoria.
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
TR200100222T2 (tr) Ürokinaz önleyicileri olarak izokinolinler
ES2166710A1 (es) Nuevos compuestos heterociclicos con actividad antiinflamatoria.
EP1300395A4 (en) 4-SUBSTITUTED PIPERIDINE CONNECTION
ATE367377T1 (de) Bis(5-aryl-2-pyridyl)derivate
WO2002033216A3 (en) Corrosion inhibitor-drag reducer combinations
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner